Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.

@article{Pouliot2012CisplatinSM,
  title={Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.},
  author={Lynn M. Pouliot and Yu-Chi Chen and J. T. Ramani Bai and Rajarashi Guha and Scott E. Martin and Michael M. Gottesman and Matthew D. Hall},
  journal={Cancer research},
  year={2012},
  volume={72 22},
  pages={5945-55}
}
Resistance to platinum-based therapies arises by multiple mechanisms, including by alterations to cell-cycle kinases that mediate G(2)-M phase arrest. In this study, we conducted parallel high-throughput screens for microRNAs (miRNA) that could restore sensitivity to cisplatin-resistant cells, and we screened for kinases targeted by miRNAs that mediated cisplatin resistance. Overexpression of the cell-cycle kinases WEE1 and CHK1 occurred commonly in cisplatin-resistant cells. miRNAs in the miR… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
34 Citations
42 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

The mechanism of action of cisplatin: from adducts to apoptosis. In:Lippert B, editor. Cisplatin: chemistry and biochemistry of a leading anticancer drug

  • A. Eastman
  • Zurich, Switzerland: Verlag Helvetica Chimica…
  • 1999
Highly Influential
7 Excerpts

Similar Papers

Loading similar papers…